Ignite Creation Date:
2024-05-06 @ 2:32 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04348708
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2022-06-30
First Post:
2020-04-13
Brief Title:
Long-Term Follow Up Study of Subjects Previously Administered HMI 102
Sponsor:
Organization:
Homology Medicines Inc
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Neutralizing AAV antibody AAV antibody IgG Anti-PAH antibody Vector DNA in blood Vector DNA in body fluids Serum Chemistry Hematology
Enrollment Count:
21
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 63875 |
Who Masked List: